RealFeedApp beta
- Do not view mTOR as a single pharmaceutical target
The study found that blocking PD-L1 in the brain restores glial cell function. Researchers advise not viewing mTOR as a single pharmaceutical target because context matters.
- Field
- ageing and longevity
- What they did
- Researchers demonstrated that blocking the protein PD-L1 in the brain restores the function of glial cells.
- Why it matters
- This could help in understanding aging mechanisms and developing treatments for age-related diseases.
#pd-l1#glial cells#mtor#aging
